Atea showcased its Phase III HCV programme at JPM for bemnifosbuvir/ruzasvir, positioning the regimen for test-and-treat ...

"Early detection and treatment of acute hepatitis C is critical to achieving the World Health Organization objective of eliminating HCV as a public health concern by 2030," says Dr. Brian Conway, ...

Mental health conditions such as alcohol use disorder and PTSD could significantly increase risk for liver cancer among ...

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

A recent study by South African academic Professor Nonhlanhla P. Khumalo has raised alarm over the risk of exposure to blood-borne viral infections during ...

Research shows that compliance-focused safety training alone rarely delivers lasting risk reduction, prompting calls for ...

Point-of-care hepatitis C virus RNA testing significantly increased testing costs compared with previous testing protocols.

An international collaborative study published in Science Bulletin reveals that over 680,000 new cases of hepatocellular ...

Organon , a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has approved ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and conduit infection increased initial hospital charges by ...